0001628280-23-028889.txt : 20230810
0001628280-23-028889.hdr.sgml : 20230810
20230810162635
ACCESSION NUMBER: 0001628280-23-028889
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230809
FILED AS OF DATE: 20230810
DATE AS OF CHANGE: 20230810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stelzer Laurie
CENTRAL INDEX KEY: 0001644348
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 231159948
MAIL ADDRESS:
STREET 1: 6154 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirati Therapeutics, Inc.
CENTRAL INDEX KEY: 0001576263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462693615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3545 CRAY COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-332-3410
MAIL ADDRESS:
STREET 1: 3545 CRAY COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wk-form4_1691699187.xml
FORM 4
X0508
4
2023-08-09
0
0001576263
Mirati Therapeutics, Inc.
MRTX
0001644348
Stelzer Laurie
C/O MIRATI THERAPEUTICS, INC
3545 CRAY COURT
SAN DIEGO
CA
92121
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-08-09
4
A
0
22297
37
A
102312
D
Grant of Restricted Stock Units (RSUs). Shares will vest 100% on the one year anniversary of the grant date.
/s/ John Moriarty, Attorney-in-Fact
2023-08-10